-
1.发明授权6-N-LINKED HETEROCYCLE-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS 有权6-N连接的杂环基取代的2,3,4,5-四氢-1H-苯并[d]氮杂作为5-HT2C受体激动剂
公开(公告)号：EP1924578B1
公开(公告)日：2013-11-06
申请号：EP06802905.7
申请日：2006-09-01
发明人： BRINER, Karin , CAMP, Anne, Marie , CORNELL, Alan , MAZANETZ, Michael, Philip Eli Lilly and Company Limited , ROTHHAAR, Roger, Ryan , VICTOR, Frantz , WILLIAMS, Andrew, Caerwyn , ZHANG, Deyi
IPC分类号： C07D403/04 , C07D405/14 , C07D409/14 , C07D223/16 , C07D401/14 , A61K31/55 , A61P25/24
CPC分类号： C07D403/04 , C07D223/16 , C07D401/14 , C07D405/14 , C07D409/14
-
2.发明公开6-N-LINKED HETEROCYCLE-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS 有权6-N连接的杂环基取代的2,3,4,5-四氢-1H-苯并[d]氮杂作为5-HT2C受体激动剂
公开(公告)号：EP1924578A2
公开(公告)日：2008-05-28
申请号：EP06802905.7
申请日：2006-09-01
发明人： BRINER, Karin , CAMP, Anne, Marie , CORNELL, Alan , MAZANETZ, Michael, Philip Eli Lilly and Company Limited , ROTHHAAR, Roger, Ryan , VICTOR, Frantz , WILLIAMS, Andrew, Caerwyn , ZHANG, Deyi
IPC分类号： C07D403/04 , C07D405/14 , C07D409/14 , C07D223/16 , C07D401/14 , A61K31/55 , A61P25/24
CPC分类号： C07D403/04 , C07D223/16 , C07D401/14 , C07D405/14 , C07D409/14
摘要： The present invention provides 6-substituted 2,3,4,5-tetrahydro-1H- benzo[d]azepines of Formula I as selective 5-HT2C receptor agonists for the treatment of 5-HT2C associated disorders including obesity, obsessive/compulsive disorder, depression, and anxiety: Formula (I) where: R6 is selected from the group consisting of (a, b, c, d, e) and other substituents are as defined in the specification.
-
搜索结果
2 条记录 (耗时 0.011 秒)
